Lupin receives USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mL – FinSiddhi

Lupin receives USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mL

Used as an alternative administration option for adult patients requiring anticoagulation therapy
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.